12 results
424B3
SYRS
Syros Pharmaceuticals Inc.
8 Aug 22
Prospectus supplement
5:47pm
to recoup Syros’ or their investment in one or more product candidates, even if Syros’ product candidates obtain marketing approval.
Patients who
S-4
SYRS
Syros Pharmaceuticals Inc.
18 Jul 22
Registration of securities issued in business combination transactions
7:58am
from the sale of the product in that country. Adverse pricing limitations may hinder Syros’ ability or the ability of any collaborators to recoup Syros
10-K
tbbmw 5kducxcv06cf
20 Mar 17
Annual report
12:00am
- Prev
- 1
- Next